The Klein Hersh Finance & Business Development practice excels in partnering with pharma and biotech organizations of all sizes, including seed stage and small-to-mid-sized biotechs, up to large pharmaceutical companies, in the recruitment of business development and finance professional at the director through senior vice president level.
Completed Searches
Finance
• CFO – Applied Molecular Therapeutics
• CFO – Bicycle Therapeutics
• CFO – Mineralys Therapeutics
• CFO – Galecto Biotech
• CFO – Kinevant Sciences
• CFO – Ribometrix
• CAO – BridgeBio
• CAO – IO Biotech
• EVP, Finance – Scorpion
• SVP, Finance – Kartos
• SVP, Finance – Rain
• VP, Finance – Fog Pharma
• VP, Finance – Beren
• VP, Strategic Finance – Xilio
• VP, Finance and Controller – Artiva
• VP, Controller – Theseus
• Controller – AVROBIO
• Controller – Syntimmune
• SVP of Investor Relations – Viridian Therapeutics
• VP of Investor Relations – Oxford Biomedica
• VP of Investor Relations – Exscientia
• VP of IR/Corporate Communications – Eikon Therapeutics
• VP of IR/Corporate Communications – RallyBio
• VP of Corporate Communications – Exscientia
• Director of Investor Relations – Corcept Therapeutics
Business Development
• CFO/CBO – Impel NeuroPharma
• COO/CBO – Twentyeight-Seven Therapeutics
• CBO – Aura Bio
• CBO – Cerevance
• CBO – Frontera Therapeutics
• CBO – ImmuneID
• CBO – Nocion Therapeuticas
• CBO – Notable Labs
• CBO – Omeros Corporation
• CBO – Peptilogics
• CBO – QurAlis
• CBO – Ribon Therapeutics
• CBO – Spring Discovery
• CBO – Tectonic Therapeutic
• CBO – TenSixteen Bio
• SVP, BD – ReCode Therapeutics
• SVP, BD – Oncternal Therapeutics
• SVP, BD – Octant Bio
• SVP, BD – IN8bio
• VP, BD – AmbAgon Therapeutics
• VP, BD – Arialys Therapeutics
• VP, BD – Transcend Therapeutics
• VP, BD – Neurona Therapeutics
• VP, Strategy & Operations – Curie Bio
• Exec. Director BD – Omega Therapeutics
To learn more about our Finance & Business Development staffing services, please contact:
